Клиническая онкогематология. Фундаментальные исследования и клиническая практика
Clinical Oncohematology. Basic Research and Clinical Practice
ISSN 1997-6933 (print)
ISSN 2500-2139 (online)
Русский English
  • Register
  • Login
Skip to main content Skip to main navigation menu Skip to site footer
Clinical Oncohematology
Basic Research and Clinical Practice

ИФ РИНЦ:     0,587
H-INDEX:        16

  • Home
  • About the Journal
    • Aims and Scope
    • Editorial Board
    • Peer Review
    • Publishing Ethics and Malpractice Statement
    • Indexing and Abstracting
    • Ownership, management and funding
    • Open Access Policy and Publication Fee
  • Articles
    • Current
    • Journal pre-proofs
    • Archive
    • SUPPLEMENT
  • Sections
    • LYMPHOID TUMORS
    • MYELOID TUMORS
    • BONE MARROW TRANSPLANTATION
    • ANEMIAS
    • AUTOIMMUNE DISEASES
    • CLINICAL TRIALS
    • NOVEL CORONAVIRUS INFECTION
    • NEWS
    • NEW TECHNOLOGIES
    • REVIEWS
    • COMPLICATIONS OF CHEMOTHERAPY
    • PRACTICAL RECOMMENDATIONS
    • RARE HEMATOLOGICAL TUMORS AND SYNDROMES
    • EXPERIMENTAL STUDIES
  • Submission
  • Register
  • Login
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Factors for Sustaining Molecular Remission after Discontinuation of Tyrosine Kinase Inhibitors Therapy in Chronic Myeloid Leukemia: Results of Non-Randomized Prospective Clinical Trial

    Oleg Aleksandrovich Shukhov, A.N. Petrova, E.Yu. Chelysheva, A.V. Bykova, I.S. Nemchenko, A.G. Turkina
    1-12
    01.01.2021
  • Gynecological Myeloid Sarcoma: Literature Review and a Case Report

    Aleksina Alekseevna Shatilova, L.L. Girshova, D.V. Zaitsev, I.G. Budaeva, Yu.V. Mirolyubova, D.V. Ryzhkova, R.V. Grozov, K.V. Bogdanov, T.S. Nikulina, D.V. Motorin, D.B. Zammoeva, S.V. Efremova, V.V. Ivanov, A.V. Petukhov, Yu.A. Alekseeva, A.Yu. Zaritskey
    31-44
    01.01.2021
  • Opportunities of Chronic Myeloid Leukemia Treatment with Reduced Doses of Tyrosine Kinase Inhibitors

    Margarita Anatolevna Guryanova, E.Yu. Chelysheva, A.G. Turkina
    118-128
    01.01.2021
  • Intermediate Results of Prospective, Randomized, Comparative Study of NHL BFM-90 and СНОЕР Efficacy in Primary ALK-Positive Anaplastic Large-Cell Lymphoma

    Liliya Gamilevna Gorenkova, S.K. Kravchenko, E.E. Klebanova, A.M. Kovrigina, K.A. Sychevskaya, E.G. Gemdzhian, E.S. Nesterova, Ya.K. Mangasarova, A.V. Misyurin, Yu.V. Sidorova, T.N. Obukhova
    382-388
    01.10.2020
  • Successful Treatment of Aplastic Anemia in the Kyrgyz Republic

    Sagynali Murzaevich Mamatov, E.M. Sadabaev, O.A. Dzhakypbaev, M.O. Eralieva
    406-410
    01.10.2020
  • Treatment of Aggressive Non-Hodgkin’s Lymphomas in Pregnancy

    Yana Konstantinovna Mangasarova, A.U. Magomedova, E.S. Nesterova, L.G. Gorenkova, F.E. Babaeva, R.G. Shmakov, S.K. Kravchenko
    316-321
    01.07.2020
  • Safety and Efficacy of BeEAC as a Conditioning Regimen Prior to Autologous Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Lymphomas

    V.O. Sarzhevskii, Anastasiya Aleksandrovna Samoilova, V.Ya. Melnichenko, Yu.N. Dubinina, N.E. Mochkin, D.S. Kolesnikova, D.A. Fedorenko, E.G. Smirnova, A.E. Bannikova, V.S. Bogatyrev
    185-192
    01.04.2020
  • Clinical Efficacy of Daratumumab in Monotherapy of Relapsed/Refractory Multiple Myeloma

    Stanislav Semenovich Bessmeltsev, E.V. Karyagina, E.Yu. Ilyushkina, Zh.L. Stolypina, R.R. Miftakhova, I.I. Kostroma, T.L. Shelkovskaya
    25-32
    01.01.2020
  • Infectious Complications after Haploidentical Hematopoietic Stem Cells Transplantation in Patients with High-Risk Tumors of Hematopoietic and Lymphoid Tissues: A Single-Center Experience

    Yurii Sergeevich Osipov, S.S. Bessmeltsev, G.N. Salogub, V.V. Ivanov, E.S. Mikhailov, N.A. Zhukova, A.V. Chechetkin
    406-415
    01.10.2019
  • Prediction of FLAG ± Ida Regimen Efficacy in Patients with Relapsed/Refractory Acute Myeloid Leukemia

    Irina Garmaevna Budaeva, E.G. Ovsyannikova, E.N. Goryunova, O.V. Kulemina, D.V. Zaitsev, D.V. Motorin, R.Sh. Badaev, D.B. Zammoeva, V.V. Ivanov, K.V. Bogdanov, O.S. Pisotskaya, Yu.V. Mirolyubova, T.S. Nikulina, Yu.A. Alekseeva, A.Yu. Zaritskey, L.L. Girshova
    289-296
    01.07.2019
  • Paroxysmal Nocturnal Hemoglobinuria in Patients with Aplastic Anemia: Challenges, Characteristics, and Analysis of Clinical Experience

    Elena Romanovna Shilova, T.V. Glazanova, Zh.V. Chubukina, O.E. Rozanova, M.N. Zenina, A.V. Seltser, V.I. Rugal, V.A. Balashova, V.A. Kobilyanskaya, I.I. Krobinets, V.Yu. Udal’eva, I.I. Zotova, L.V. Stelmashenko, N.A. Romanenko, T.B. Zamotina, I.V. Khorsheva, S.V. Voloshin
    319-328
    01.07.2019
  • Intermediate Results of Prospective Observational Study: The 2-year Experience of Ibrutinib Therapy in Relapsed/Refractory Mantle Cell Lymphoma in Clinical Practice

    Vladimir Ivanovich Vorob’ev, V.A. Zherebtsova, E.I. Dubrovin, L.A. Bychenkova, Yu.B. Kochkareva, L.A. Mukha, V.L. Ivanova, N.K. Khuazheva, V.V. Ptushkin
    165-172
    01.04.2019
  • Treatment of Chronic Myeloid Leukemia According to Current Guidelines: The Results of the Pilot Prospective Study “Early Induction Therapy and Monitoring” (РИТМ)

    Oleg Aleksandrovich Shukhov, A.G. Turkina, E.Yu. Chelysheva, A.V. Bykova, A.N. Petrova, G.A. Gusarova, I.S. Nemchenko, A.O. Abdullaev, T.N. Obukhova, A.B. Sudarikov
    194-201
    01.04.2019
  • Blinatumomab in the Treatment of Acute Lymphoblastic Leukemia: Russian Multicenter Clinical Trial

    Sergei Nikolaevich Bondarenko, E.N. Parovichnikova, A.A. Maschan, O.Yu. Baranova, T.V. Shelekhova, V.A. Doronin, V.Ya. Mel’nichenko, K.D. Kaplanov, O.S. Uspenskaya, A.N. Sokolov, N.V. Myakova, I.S. Moiseev, I.V. Markova, E.I. Darskaya, A.G. Smirnova, T.A. Bykova, B.I. Ayubova, I.A. Samorodova, E.V. Babenko, I.M. Barkhatov, T.L. Gindina, A.D. Kulagin, B.V. Afanas’ev
    145-153
    01.04.2019
  • Primary Mediastinal (Thymic) Large B-Cell Lymphoma: Experience in Treating 131 Patients at a National Medical Research Center in Russia

    I.Z. Zavodnova, M.Yu. Kichigina, E.V. Paramonova, Yu.E. Ryabukhina, O.A. Kolomeitsev, O.P. Trofimova, N.V. Volkova, Yu.I. Pryamikova, N.V. Kokosadze, Gayane Sergeevna Tumyan
    59-67
    01.01.2019
  • Preventive Use of Azacitidine in Patients with Acute Myeloid Leukemia after Haploidentical Allo-BMT

    R.Sh. Badaev, D.B. Zammoeva, L.L. Girshova, D.V. Babenetskaya, N.A. Il’ina, Yu.A. Alekseeva, A.Yu. Zaritskey, Dmitrii Vasil’evich Motorin
    37-42
    01.01.2019
  • Magnetic Resonance Imaging of Bone Marrow and its Results as a Criterion for Administration of Maintenance Therapy After Auto-HSCT in Multiple Myeloma Patients

    Maksim Valer’evich Solov’ev, L.P. Mendeleeva, G.A. Yatsyk, N.S. Lutsik, M.V. Firsova, E.G. Gemdzhian, V.G. Savchenko
    360-367
    01.10.2018
  • Outcome of Classical Hodgkin’s Lymphoma Treatment Based on High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation: The Experience in the NI Pirogov Russian National Medical Center of Surgery

    Nikita Evgen’evich Mochkin, V.O. Sarzhevskii, Yu.N. Dubinina, E.G. Smirnova, D.A. Fedorenko, A.E. Bannikova, D.S. Kolesnikova, V.S. Bogatyrev, N.M. Faddeev, V.Ya. Mel’nichenko
    234-240
    01.07.2018
  • Pure Red Cell Aplasia with M-Gradient: A Literature Review and Clinical Experience

    Aleksandr Vasil’evich Pivnik, A.A. Petrenko, S.V. Kozhurin, S.A. Mar’ina
    273-280
    01.07.2018
  • Results of Molecular Monitoring in Posttransplant Period by Means of Series Investigation of WT1 Gene Expression in Patients with Acute Myeloid Leukemia

    Ya.V. Gudozhnikova, Nikolai Nikolaevich Mamaev, I.M. Barkhatov, V.A. Katerina, T.L. Gindina, A.I. Shakirova, S.N. Bondarenko, O.A. Slesarchuk, E.I. Darskaya, O.V. Paina, L.S. Zubarovskaya, B.V. Afanas’ev
    241-251
    01.07.2018
  • Minimal Residual Disease and IGHV-Genes Mutational Status as the Main Predictors of Response to Bendamustine-Rituximab Therapy in Previously Untreated Chronic Lymphocytic Leukemia

    Yuliya Vladimirovna Mirolyubova, E.A. Stadnik, V.V. Strugov, T.O. Andreeva, T.S. Nikulina, Yu.V. Virts, P.A. Butylin, A.G. Rumyantsev, A.Yu. Zaritskey
    167-174
    01.04.2018
  • First-Line Treatment of Mantle-Cell Lymphoma: Analysis of Effectiveness and Cost-Effectiveness

    Kamil’ Daniyalovich Kaplanov, N.P. Volkov, T.Yu. Klitochenko, A.L. Shipaeva, I.V. Matveeva, M.N. Shirokova, A.C. Proskurina, N.A. Red’kina, E.G. Gemdzhyan
    150-159
    01.04.2018
  • Epstein-Barr Virus in Patients with Classical Hodgkin’s Lymphoma

    Vladimir Eduardovich Gurtsevitch, E.A. Demina, N.B. Senyuta, I.V. Botezatu, K.V. Smirnova, T.E. Dushen’kina, D.M. Maksimovich, U.V. Paramonova, I.S. Monin, A.V. Lichtenshtein
    160-166
    01.04.2018
  • Prognostic Value of Genetic Markers for Efficacy Estimation of Induction Treatment Including Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Patients

    Elena L’vovna Nazarova, N.V. Minaeva, M.N. Khorobrykh, E.E. Sukhorukova, V.I. Shardakov, I.V. Paramonov, N.A. Zorina
    54-69
    01.01.2018
  • Conventional and Conformal Radiotherapy with and without Beam Intensity Modulation in Patients with Stage II Hodgkin’s Lymphoma with Supradiaphragmal Lesions

    Yu.N. Vinogradova, E.I. Ivanova, A.I. Chumachenko, E.V. Smirnova, G.I. Andreev, A.M. Kalesnik, N.A. Vorob’ev, N.V. Il’in
    70-77
    01.01.2018
  • Thrombotic and Hemorrhagic Complications in the Treatment of Acute Lymphoblastic Leukemia with L-Asparaginase

    Gennadii Martinovich Galstyan, O.A. Polevodova, A.V. Bazhenov, V.V. Troitskaya, O.A. Gavrilina, D.G. Gitel’zon, A.E. Vasil’ev, E.N. Parovichnikova
    89-99
    01.01.2018
  • First-Line Therapy for Patients with Advanced Hodgkin’s Lymphoma: Efficacy and Toxicity of Intensive ЕАСОРР-14 Program (NN Blokhin National Medical Cancer Research Center Data)

    Elena Andreevna Demina, A.A. Leont’eva, G.S. Tumyan, Yu.E. Ryabukhina, O.P. Trofimova, N.V. Volkova, Yu.I. Pryamikova, V.M. Sotnikov, V.B. Larionova, E.G. Medvedovskaya, E.V. Paramonova, L.V. Manzyuk, N.A. Probatova, N.V. Kokosadze, E.A. Osmanov
    443-452
    01.10.2017
  • Acute Lymphoblastic Leukemia with t(4;11)(q21;q23)/KMT2A-AFF1 Translocation: The Results of Allogeneic Hematopoietic Stem Cells Transplantation in Children and Adults

    Tat’yana Leonidovna Gindina, N.N. Mamaev, O.V. Paina, A.S. Borovkova, P.V. Kozhokar’, O.A. Slesarchuk, Ya.V. Gudozhnikova, E.I. Darskaya, A.L. Alyanskii, S.N. Bondarenko, L.S. Zubarovskaya, B.V. Afanas’ev
    342-350
    01.07.2017
  • Ibrutinib in the Treatment of Refractory Chronic Lymphocytic Leukemia

    Evgenii Aleksandrovich Nikitin, E.A. Dmitrieva, M.A. Panteleev, E.I. Emelina, V.L. Ivanova, Yu.B. Kochkareva, E.G. Arshanskaya, I.E. Lazarev, E.E. Markova, L.A. Mukha, N.G. Novitskaya, M.M. Pankrashkina, V.V. Glazunova, A.V. Shubina, S.A. Chernysh, N.K. Khuazheva, E.V. Naumova, S.A. Lugovskaya, M.E. Pochtar’, T.N. Obukhova, O.Yu. Vinogradova, G.E. Gendlin, V.V. Ptushkin
    271-281
    01.07.2017
  • Treatment of Drug-Resistant Mycosis Fungoides and Sezary Syndrome

    Liliya Gamilevna Gorenkova, E.A. Penskaya, S.K. Kravchenko, A.M. Kovrigina, T.N. Moiseeva, A.I. Vorob’ev
    366-371
    01.07.2017
  • Bortezomib Combination Therapy of Relapsed and Refractory Acute Lymphoblastic Leukemia in Children

    Natal’ya Andreevna Batmanova, M.A. Shervashidze, A.V. Popa, L.Yu. Grivtsova, I.N. Serebryakova, G.L. Mentkevich
    381-389
    01.07.2017
  • V(D)J Recombination Excision Circles of B- and T-cells as Prognostic Marker in B-Cell Chronic Lymphocytic Leukemia

    Igor’ Vladimirovich Obraztsov, M.A. Gordukova, N.A. Severina, B.V. Biderman, S.Yu. Smirnova, A.B. Sudarikov, E.A. Nikitin, A.G. Rumyantsev
    131-140
    01.04.2017
  • Effect of IGHV Gene Mutation Status and BCR Structure Stereotypy on Effectiveness of BR Regimen in First-Line Therapy of Chronic Lymphocytic Leukemia

    Vladimir Vladimirovich Strugov, E.A. Stadnik, A.M. Rumyantsev, T.O. Andreeva, Yu.V. Virts, Yu.V. Mirolyubova, P.A. Butylin, A.Yu. Zaritskey
    141-149
    01.04.2017
  • Thrombopoietin Receptor Agonists in Treatment of Idiopathic Thrompocytopenic Purpura (Primary Immune Thrombocytopenia): Efficacy and Safety in Everyday Clinical Practice

    Irina Ivanovna Zotova, S.V. Gritsaev, E.R. Shilova, N.A. Potikhonova, K.М. Abdulkadyrov, A.V. Chechetkin
    93-100
    01.01.2017
  • Molecular Monitoring of RUNX1-RUNX1T1 Transcript Level in Acute Myeloblastic Leukemias on Treatment

    L.L. Girshova, Ekaterina Gennad’evna Ovsyannikova, S.O. Kuzin, E.N. Goryunova, R.I. Vabishchevich, A.V. Petrov, D.V. Motorin, D.V. Babenetskaya, V.V. Ivanov, K.V. Bogdanov, I.V. Kholopova, T.S. Nikulina, Yu.V. Mirolyubova, Yu.A. Alekseeva, A.Yu. Zaritskii
    456-464
    01.10.2016
  • Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis

    M.V. Barabanshchikova, E.V. Morozova, V.V. Baikov, I.M. Barkhatov, N.N. Mamaev, S.N. Bondarenko, A.L. Alyanskii, Lyudmila Stepanovna Zubarovskaya, B.V. Afanas’ev
    279-286
    01.07.2016
  • NK-Cell Lymphoblastic Leukemia/Lymphoma (Literature Review and Authors’ Experience)

    M.A. Frenkel’, O.Yu. Baranova, Alina Sergeevna Antipova, N.A. Kupryshina, N.N. Tupitsyn
    208-217
    01.04.2016
  • Chronic Myeloid Leukemia: Long-Term Experience of Target Therapy

    K.M. Abdulkadyrov, Vasilii Anatol’evich Shuvaev, I.S. Martynkevich, M.S. Fominykh, N.A. Potikhonova, I.I. Zotova, V.Yu. Udal’eva, R.A. Golovchenko, N.V. Shakhvorostova, D.I. Shikhbabaeva, M.N. Zenina, S.A. Tiranova, S.A. Kudryashova, L.S. Martynenko, M.P. Ivanova, N.Yu. Tsybakova, E.V. Petrova, L.B. Polushkina, E.V. Kleina
    54-60
    01.01.2016
  • Prognostic Significance of Thymidine Kinase-1 versus β2-Microglobulin and Lactate Dehydrogenase in Lymphoproliferative Diseases

    Natal’ya Konstantinovna Parilova, N.S. Sergeeva, N.V. Marshutina, N.G. Tyurina, I.S. Meisner
    6-12
    01.01.2016
  • Polycythemia Vera: Literature Review and Own Data

    Irina Nikolaevna Subortseva, T.I. Kolosheinova, E.I. Pustovaya, E.K. Egorova, A.M. Kovrigina, Yu.V. Pliskunova, T.V. Makarik, A.O. Abdullaev, A.L. Melikyan
    397-412
    01.10.2015
41 - 80 of 98 items << < 1 2 3 > >> 

oa-antiplagiat

Антиплагиат

Make a Submission

Make a Submission

Banner ROHS

Russian Oncohematology Society

Indexing Databases

  • ISSN
  • cyberleninka cyberleninka
  • DOAJ
  • Web of Science
  • Scopus
  • Elsevier
  • CAS Source Index (CASSI)
  • NLM Catalog
  • British Library
  • РИНЦ
  • Science Index
  • SCImago
  • The European Library
  • Scholia
  • Journal Observatory
  • Scholar Google
  • IPR Smart
  • RSL
  • Ulrich's Serials Analysis System
  • ВИНИТИ
  • WorldCat
  • Research4Life
  • Lens
  • Mendeley
  • MIAR
  • OpenCitations
  • xueshu
  • OpenAlex
  • Scilit
  • Wikidata
  • na.neicon
  • Internet Archive scholar
  • ZDB catalogue
  • Keepers ISSN
  • RusMed
  • RCSI

Editor-in-Chief

Gayane Sepugovna Tumyan

ARCHIVE

2026
  • Issue 1 (2026)
  • Issue 2 (2026)
  • Issue 3 (2026)
2025
  • Issue 1 (2025)
  • Issue 2 (2025)
  • Issue 3 (2025)
  • Issue 4 (2025)
2024
  • Issue 1 (2024)
  • Issue 2 (2024)
  • Issue 3 (2024)
  • Issue 4 (2024)
2023
  • Issue 1 (2023)
  • Issue 2 (2023)
  • Issue 3 (2023)
  • Issue 4 (2023)
2022
  • Issue 1 (2022)
  • Issue 2 (2022)
  • Issue 3 (2022)
  • Issue 4 (2022)
2021
  • Issue 1 (2021)
  • Issue 2 (2021)
  • Issue 3 (2021)
  • Issue 4 (2021)
2020
  • Issue 1 (2020)
  • Issue 2 (2020)
  • Issue 3 (2020)
  • Issue 4 (2020)
2019
  • Issue 1 (2019)
  • Issue 2 (2019)
  • Issue 3 (2019)
  • Issue 4 (2019)
2018
  • Issue 1 (2018)
  • Issue 2 (2018)
  • Issue 3 (2018)
  • Issue 4 (2018)
2017
  • Issue 1 (2017)
  • Issue 2 (2017)
  • Issue 3 (2017)
  • Issue 4 (2017)
2016
  • Issue 1 (2016)
  • Issue 2 (2016)
  • Issue 3 (2016)
  • Issue 4 (2016)
2015
  • Issue 1 (2015)
  • Issue 2 (2015)
  • Issue 3 (2015)
  • Issue 4 (2015)
2014
  • Issue 1 (2014)
  • Issue 2 (2014)
  • Issue 3 (2014)
  • Issue 4 (2014)
2013
  • Issue 1 (2013)
  • Issue 2 (2013)
  • Issue 3 (2013)
  • Issue 4 (2013)
ALL ARCHIVE

Keywords

Most Read Articles
  • National Clinical Guidelines on Diagnosis and Treatment of Ph-Negative Myeloproliferative Neoplasms (Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis) (Edition 2020)
    402
  • National Clinical Guidelines on Diagnosis and Treatment of Ph-Negative Myeloproliferative Neoplasms (Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis) (Edition 2024)
    400
  • Current Quality-of-Life Aspects in Patients with Classical Ph-Negative Myeloproliferative Neoplasms in the Russian Federation: Results and Discussion of the National Observational Program MPN-QoL-2020
    283
  • Obinutuzumab-Based Regimens in the First-Line Therapy for Follicular Lymphoma: Data from Real-World Clinical Practice in 41 Medical Institutions
    277
  • Efficacy and Safety of Glofitamab Therapy in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A United Russian Experience Based on the Compassionate Use Program
    215
  • Ponatinib Efficacy in Chronic Phase Chronic Myeloid Leukemia: Data from Three Centers in the Russian Federation
    197
  • Efficacy and Safety of Various Treatment Regimens for Primary CNS Lymphoma: Results of a Retrospective Study Based on the Data from Nine Saint Petersburg Medical Institutions
    170
  • Gilteritinib for Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia: from Biology to Clinical Practice (Experience of the AF Tsyb Medical Radiological Research Center)
    167
  • Materials of the II Conference “Current Issues of Diagnosis and Treatment of Ph-Negative and Ph-Positive Myeloproliferative Neoplasms” (March 15–16, 2019; National Research Center for Hematology, Moscow)
    149
  • Results of a Double-Blind Prospective Comparative Randomized Phase 3 Clinical Trial of the Efficacy and Safety of BCD-264 and Darzalex as Monotherapy for Relapsed/Refractory Multiple Myeloma (BCD-264-2/DARVIVA)
    141

Partners

Roche
Novartis Pharma
AstraZeneca
AbbVie
Swedish Orphan Biovitrum / SOBI
Roche
Novartis Pharma
AstraZeneca
AbbVie
Swedish Orphan Biovitrum / SOBI

«PRACTICAL MEDICINE» LLC
115201, Moscow, 1st Kotlyakovsky Pereulok 3
Phone. +7 (495) 324-93-29
E-mail: org@bloodjournal.ru
medprint.ru


Copyright © Clinical Oncohematology. Basic Research and Clinical Practice 2026

Up